Using a type of mesenchymal stem cell called LIF nano (leukemia inhibitory factor), which opposes the cytokine storm of viral pneumonia, the patient’s biological resistance to COVID-19 was improved [247]. The gene discussed is LIF; the disease is viral pneumonia.